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Abstract 
Purpose: To determine levels of urinary AFM1 in children and correlate the concentrations with 
previously reported aflatoxin albumin adduct (AF-alb) levels in these children. 
Materials and Methods: Matched urine and blood samples were collected from 84 Tanzanian children 
aged 6-14 months old. From 31 children in one village (Kigwa), samples were collected at three time 
points six months apart. Samples were collected from 31 and 22 children from two different regions at 
the second time point only. Urinary AFM1 was measured using a commercial ELISA kit with a 
modified protocol to improve sensitivity. AF-alb was measured using an established ELISA method. 
Results: The relative ranking of the three villages for exposure to aflatoxin based on either AFM1 or 
AF-alb biomarker measurements was the same. In Kigwa village, both AFM1 and AF-alb levels were 
higher at six months post-harvest compared to baseline. However, at the next visit the AFM1 levels 
dropped from a GM (interquartile range) of 71.0 (44.7, 112.6) at visit two to 49.3 (31.5, 77.3) pg/ml 
urine, whereas AF-alb levels increased from 47.3 (29.7, 75.2) to 52.7 (35.4, 78.3) pg/mg albumin 
between these two visits, reflecting the fact that AFM1 measures short term exposure whereas AF-alb 
measures longer term exposure. There was a correlation between AFB1 intake and AFM1 excretion (r 
= 0.442, p = < 0.001).  
Conclusions: Urinary AFM1 is a good biomarker for AFB1 exposure in Tanzanian children, reflecting 
geographical and temporal variations in exposure to this food borne toxin.  
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Introduction  
Aflatoxins are a group of fungal toxins produced by Aspergillus flavus and Aspergillus parasiticus in 
a variety of food crops either before harvest or during postharvest storage (IARC, 2002; Pitt et al, 
2013), with aflatoxin B1 (AFB1) being the most common and most toxic. Epidemiological studies 
have demonstrated a correlation between chronic exposure to aflatoxins and increasing risk of primary 
liver cancer (IARC, 2002). Moreover, chronic exposure to aflatoxin has been linked to child growth 
impairment (Gong et al, 2002; 2004) and immune suppression (Turner et al, 2003; Jiang et al, 2008). 
Approximately 1 million child deaths each year have been attributed to child stunting, wasting and 
micronutrient deficiencies (Black et al, 2013) and aflatoxin may be contributing to this toll, as 
aflatoxin contamination of weaning food made from maize and groundnuts frequently affects this 
vulnerable group in sub-Saharan Africa.  
When food contaminated with aflatoxin is consumed by humans, part of the ingested toxin is 
metabolised by the liver to form metabolites that can be detected in human biological samples, 
including aflatoxin albumin adduct (AF-alb) in blood, aflatoxin N7 guanine in urine, and aflatoxin M1 
(AFM1) in urine or in breast milk. These metabolites can also serve as biomarkers of aflatoxin 
exposure (Routledge and Gong, 2011). One of the most frequently used biomarkers of aflatoxin 
exposure is AF-alb, which represents exposure over the past 2-3 months, based on albumin half-life 
(Chapot and Wild, 1991). Previous studies in which this biomarker has been applied have shown that 
aflatoxin exposure is common in some African populations and is associated with adverse health 
outcomes including deaths due to acute poisoning (Wild and Gong, 2010). AFM1 can be detected in 
urine and has served as a biomarker of recent (24 hour) exposure to aflatoxin in adult populations for 
many years (Zhu et al, 1987; Groopman et al, 1992). However, few studies have assessed AFM1 in 
FKLOGUHQ¶VXULQHDQGWKHUHODWLRQVKLSEHWZHHQWKHOHYHOVRI$)0DQG$)-alb in children has not yet 
been established.  
We have previously published results from a study of dietary exposure of Tanzanian children to 
mycotoxins, in which AF-alb was used to assess exposure to aflatoxin (Shirima et al, 2013; 2015; 
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Routledge et al, 2014). The urine samples collected from the children during the previous study 
provides an opportunity to analyse urinary AFM1, using an optimised commercial direct ELISA kit, 
and compare AFM1 and AF-alb biomarkers of aflatoxin exposure in young children.  
Clinical Significance 
The measurement of AFM1 as a marker of aflatoxin exposure may benefit molecular epidemiology 
studies of the impact of aflatoxin on health. 
Materials and methods 
Subjects and sample collection 
Urine and blood samples were collected from a cohort of children aged 6-14 months old (n =84). The 
children were from three villages; Kigwa, Nyabula and Kikelelwa in Tabora, Iringa and Kilimanjaro 
regions in Tanzania, respectively. Ethical approval was obtained from the National Institute of 
Medical Research in Tanzania and the University of Leeds, United Kingdom (HSLT/09/005), 
following review of the human subjects research proposal. Informed written consent was obtained 
from the mothers or children¶V care takers. Out of  the 84 studied children,  31 were from Kigwa 
village (Kilimanjaro region), and their urine samples were collected at a series of three visits; at maize 
harvest season (July 2010), six months later (January 2011), then finally at the new maize harvest 
season (July 2011). In other children (31 from Nyabula village in Iringa region and 22 from Kikelelwa 
village in Kilimanjaro region), the urine samples available for analysis were those which  were 
collected at one survey point only (six months after the harvest in January 2011) as opposed to Kigwa 
village in which the urine samples were from all three survey points.  
Maize intake and AFB1 contamination levels 
Maize intake for each child was calculated based on a 24-h dietary recall questionnaire administered 
at the visit when urine samples were collected (Shirima et al, 2015). Levels of AFB1 contamination in 
dried maize porridge samples taken from each family at the same time were measured by a standard 
HPLC method (Stroka et al, 2000) in the Tanzania and Food Drug Authority laboratory as previously 
reported (Routledge et al, 2014). 
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Analysis of aflatoxin-albumin adducts in blood 
The methodology for collection of blood samples from these children and the subsequent analysis of 
AF-alb is as previously reported (Shirima et al, 2013). Briefly, albumin was extracted from blood, 
digested, purified and AF-alb was detected by a competitive ELISA using a rabbit polyclonal 
antibody (Chapot and Wild 1991). The method detection limit was 3 pg/mg albumin. Only those AF-
alb results for which matched urine collections were available are included in the present study.  
 
Analysis of urinary AFM1 
The first morning urine sample from each child was collected by the mother or child caretaker on two 
consecutive days using paediatric urine bags. The urine samples were kept in a cold box immediately 
after collection and were then kept frozen at -80 oC prior to analysis. Urinary AFM1 as a biomarker of 
aflatoxin exposure was determined using the Helica AFM1 ELISA kit (Helica Biosystem, Inc., Santa 
Ana, CA, USA), according to PDQXIDFWXUHU¶VLQVWUXFWLRQs but with some minor modifications. In brief, 
following urine centrifugation, 50 µl of the supernatant was mixed with the same volume of water 
before 200 µl assay buffer was mixed in. 7KLVLVDPRGLILFDWLRQRIWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVDV
the dilution of the sample here was 1:1 rather than 1:19. This allows for the detection of lower 
concentrations of AFM1 in the sample. 100 µl of the mixture was transferred onto a microplate pre-
coated with a mouse anti-AFM1 monoclonal antibody to allow binding of AFM1 in the sample to the 
antibody on the plate. This was followed by incubation with 100 µl of aflatoxin horseradish peroxide 
conjugate for 15 minutes to allow for binding of the conjugate to the remaining unbound coated 
antibody. After reaction of the conjugated enzyme with the substrate, colour was read at 450 nm using 
a plate reader. Each sample was tested in duplicate. A urine matrix standard was used for the 
calculation of the sample concentration. The limit of detection was 15 pg/ml, and the recovery ranged 
from 73-111%, which was in consistent with WKHPDQXIDFWXUH¶VPDQXDO 
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Two blank urine samples were spiked with AFM1 at 200 and 500 pg/ml to serve as Quality Controls 
(QCs) that were run alongside each batch of samples. Additionally, the QCs were tested with 
sequential dilution at 1:2, 1:5 and 1:20 in order to investigate the recovery. 
 
Statistical analysis 
Concentrations of AFM1 and AF-alb were not normally distributed and therefore non-parametric tests 
were used for statistical analysis for tests which involved these parameters and data was presented as 
median and inter-quartile range. For the data analysis, samples with AFM1 or AF-alb levels below the 
LOD were assigned half the value of the detection limit. Friedman and Wilcoxon signed-rank tests 
were used to investigate the seasonal differences between AFM1 concentrations measured at various 
recruitment times, for the children from the Tabora region (n = 31). Non-SDUDPHWULF6SHDUPDQ¶VWHVW
was used for all the correlation analyses.  
A p-YDOXHRIZDVFRQVLGHUHGstatistically significant except for IRU6SHDUPDQ¶VWHVW$OO
statistical analyses were performed using the IBM SPSS Statistics for Windows version 20 (SPSS Inc, 
Chicago, IL, USA). 
 
Results  
Assay accuracy and precision 
The determination of the accuracy and precision of the assay was by the analysis of two QCs with 
spiked concentration of 200 and 500 pg/ml in blank urine that were diluted to give a range of 
concentrations of AFM1 to be measured (see Table 1). As a measure of accuracy of the method, the 
recovery varied between 90% and 119% of the true value. The precision of the method was expressed 
as the coefficient of variance (CV%), which was never higher than 11%. Because the samples are 
only diluted 1 in 2, rather WKDQLQDVSHUWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVWKH/2'LVLQFUHDVHGWR
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15 pg/ml. Table 1 shows that even 10 pg/ml in diluted spiked standards was detectable with good 
accuracy. 
 
Levels of urinary AFM1  
AFM1 was detected in 86% of samples tested at a level above LOD, ranging from 15 to 2840 pg/ml; 
geometric mean (GM) (95% confidence interval) 36.5 (30.8, 46.3) pg/ml. The GM urinary AFM1, 
collected from Kigwa village (Tabora region) at the three survey points are shown in Table 2, along 
with AF-alb values from the same children. A significant difference in mean levels of AFM1 between 
the three survey points was observed (p = 0.024). At recruitment, AFM1 was detected in 87% of the 
children, with a GM concentration of 42.5 pg/ml (95% CI: 27.2, 66.5). The prevalence of positive 
samples and GM concentration increased to 100% and 71.0 pg/ml (95% CI: 44.7, 112.6), respectively 
at 6 months after recruitment. At the final visit, the GM concentration of AFM1 was 49.3 pg/ml (95% 
CI: 31.5, 77.3) with 87% of samples testing positive.  
Geographical variation in levels of urinary AFM1 
Results of urinary AFM1 from the three studied villages as obtained based on urine samples from the 
second survey point are presented in Table 3. A significant difference in levels of urinary AFM1 
among villages was observed (p < 0.001). The GM AFM1 was the highest in Kigwa, Tabora region 
(71 pg/ml) and lowest in Kikelelwa, Kilimanjaro region (12.9 pg/ml), with intermediate levels in 
Nyabula, Iringa region (29.3 pg/ml). The proportion of samples with detectable levels of AFM1 
showed a similar hierarchy of exposure, with 100% in Kigwa, 90% in Nyabula, and 59% in Kikelelwa.  
Correlation of urinary AFM1 and AF-alb 
When the levels of urinary AFM1 and AF-alb from the study individuals were compared, a highly 
significant correlation (r = 0.468, p < 0.001) of AFM1 with AF-alb was seen (Figure 1). There was a 
similar pattern of aflatoxin exposure across the three geographical regions for both biomarkers, with 
the ranking of exposure between villages being determined as Kigwa>Nyabula>Kikelelwa using 
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either AFM1 or  AF-alb. However, when comparing the levels of exposure across three time points in 
Kigwa village, there was a difference in the relative levels of biomarker between visits two and three, 
with AFM1 GM (IQR) reducing from 71.0 (44.7, 112.6) pg/ml urine at visit two to 49.3 (31.5, 77.3) 
pg/ml urine, whereas AF-alb levels increased from 47.3 (29.7, 75.2) to 52.7 (35.4, 78.3) pg/mg 
albumin at visit three.  
Correlation of urinary AFM1 and AFB1 in the consumed maize 
AFM1 levels were compared to previously reported food intake and AFB1 contamination data for the 
families in this study (Routledge et al, 2014). Figure 2 shows that urinary AFM1 also correlated with 
AFB1 contamination levels measured in family maize samples (r = 0.442, p < 0.001).  
 
Discussion 
This is the first study to compare AFM1 and AF-alb biomarker levels in samples collected in very 
young children from a longitudinal study. Whilst the detection of the AF-alb biomarker allows for 
integration of aflatoxin exposure over the previous 2-3 months (Skipper and Tannenbaum, 1990), 
urine collection is less invasive, which is of particular relevance when sampling biomarkers in young 
children. The urinary biomarker AFM1 has previously been compared to AF-alb biomarker levels in 
adults in a cross sectional study (Gan et al, 1988) but potential differences in metabolism and 
excretion between adults and children require confirmation that the two biomarkers are comparable in 
children.  
In this study, the GM for AFM1 of 36.5 (30.8, 46.3) pg/ml is higher than the levels previously found 
in urine of children aged 2-4 years in Guinea (GM = 16.3 pg/ml) in which AFM1 was detected in 
urine from 32 out of 50 children (Polychronaki et al, 2008). In the same study, 4/50 samples from 
Egyptian children aged 1-2.5 years showed detectable levels of AFM1, with a GM of 5.5 pg/ml. 
Another study in Nigeria using a multibiomarker method reported a low percentage of children with 
detectable AFM1 (Ezekiel et al, 2014), but that method had a much higher limit of detection (150 
pg/ml), making comparisons difficult.  
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In adults, a range of AFM1 in urine has been reported in several studies in countries where aflatoxin 
exposure is common. In 2006, Jolly et al reported mean levels of 1,800 pg/mg creatinine in adults in 
Ghana. More recently, Redzwan et al (2012) found mean levels of 23.4 pg/ml urine in 160 adults in 
Malaysia, Lei et al (2013) reported a GM of 50.3 pg/ml in 600 adults in China and Ali et al (2016) 
reported a mean of 80 pg/ml in 95 adults from Bangladesh. 
The ELISA method used to detect AFM1 in the current study is a minor modification of a 
commercially available kit ELISA, which makes the application of the method widely available. This 
ELISA kit was previously used in the study of exposure in Malaysian adults by Redzwan et al (2012) 
and more recently by Ali et al in Bangladesh (Ali et al, 2016). In the current study, the ELISA was 
validated after inclusion of dilution of the urine samples, to give a limit of detection of 15 pg/ml of 
urine. Although the change in dilution factor may have altered how the assay performs compared to 
WKHPDQXIDFWXUHU¶VSURWRFROZHKDYHYDOLGDWHGWKHDFFXUDF\DQGSUHFLVLRQRIWKHDVVD\XVLQJTXDOLW\
controls of known concentration and find that the assay performs reliably. We have not validated the 
selectivity of the modified assay. The advantage of this method is the high throughput and low cost of 
ELISA compared to HPLC quantification. It can be argued that HPLC can give more accurate results 
if multiple metabolites of aflatoxin are present, due to cross reaction of the antibody in the ELISA. 
Nevertheless, AFM1 is the most common metabolite of AFB1 in urine (Groopman et al, 1992), so 
results are unlikely to be distorted by possible co-detection of other metabolites. Recently, it has been 
reported that the method can produce false positive results at low concentrations of AFM1 
(Schwartzbord et al, 2016), although that study used urine samples from Haiti, where exposure to 
aflatoxin was much lower than in Tanzania, and reported a limit of detection (200 pg/ml) that was 
much less sensitive than the LOD we report here (15 pg/ml). In addition, the relative exposure levels 
for children as measured by AFM1 ELISA in our study are supported by the results from the AF-alb 
biomarker analysis in the same children.  
Our results reflect the seasonal variation of aflatoxin contamination that has been reported elsewhere 
(Castelino et al, 2014). An increase in aflatoxin contamination occurs after storage due to increased 
fungal growth and toxin production (Hell et al, 2003), which was reflected in the AFM1 results here, 
with levels higher at the second visit, when stored maize was being consumed. Levels of AFM1 were 
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then lower at the third visit when newly harvested maize was being consumed. It can be seen from 
Table 2 that a similar post harvest increase in exposure was determined using the AF-alb biomarker, 
with a large increase between visit 1 and visit 2. However, the subsequent drop in AFM1 seen at visit 
3 was not seen for the AF-alb biomarker. This reflects the fact that the AF-alb biomarker integrates 
exposure over the preceding 2-3 months (due to the half-life of albumin in blood) rather than the 
short-term (24 hour) exposure measured by the urinary AFM1 biomarker. Therefore, at visit 3, 
compared to the AF-alb, the AFM1 biomarker better reflects the recent aflatoxin intake from the 
newly harvested maize.  
There is a similar pattern of AFM1 and AF-alb biomarker levels within the same village for all three 
villages from different regions of Tanzania, with both biomarkers showing that exposure was highest 
in Kigwa and lowest in Kikelelwa. We have previously reported that contamination of maize flour 
was much more common in Kigwa compared to the other regions (Geary et al, 2016). Such 
differences between regions reflect differences in climate and soil conditions (Kimanya et al, 2008). 
The correlation we saw between AFM1 levels and AFB1 measured in maize flour is in agreement with 
an earlier study in China (Zhu et al, 1987; Gan et al, 1988), in adults.  
 
Conclusions  
In this study, a commercial ELISA kit protocol was modified to optimise detection of AFM1. 
Application of this method to samples from a cohort of children in Tanzania shows that urinary AFM1 
is a good biomarker of recent exposure to aflatoxin in children, and that this biomarker correlates well 
with the AF-alb biomarker in children. Collection of urine is less invasive than collection of blood and 
the availability of the ELISA kit means that this method may be widely applicable in developing 
countries. 
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Table 1. Accuracy and Precision of assay 
 
 
 
 
 
 
 
 
 
 
125, 100 and 250 pg/ml concentrations were diluted from a 500 pg/ml spiked urine sample 
10 and 40 pg/ml concentrations were diluted from a 200 pg/ml spiked urine sample 
2
 n = 3 
 
AFM1 Concentration  
(pg/ml)1 
Measured AFM1 
(pg/ml) Mean ± SD2 CV % 
10 10.3 ± 1.0 9 
25 29.7 ± 3.0 10 
40 47.0 ± 5.5 11 
100 106.8 ± 11.6 11 
250 223.5 ± 21.5 9 
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Table 2. Prevalence of detectable samples and geometric mean level (95% confidence interval) of 
AFM1 (with range) and AF-alb in children at Kigwa village in Tabora Region by visit (sampling time 
point). 
 
Visit 1 Visit 2 Visit 3 
 
AFM1 detectable (%) 
 
87 
 
100 
 
87 
 
AFM1 Geometric mean (95% 
CI)1 
 
42.5 (27.2, 66.5) 
 
71.0 (44.7, 112.6) 
 
49.3 (31.5, 77.3) 
 
AFM1 Range1 
 
AF-alb detectable (%) 
 
ND3 ± 886  
 
92 
 
15.1 ± 1950 
 
97 
 
ND ± 2840  
 
100 
 
AF-alb geometric mean (95% 
CI)2 
 
9.3 (6.6, 13.1) 
 
47.3 (29.7, 75.2) 
 
52.7 (35.4, 78.3) 
1AFM1, pg/ml urine; 2AF-alb, pg/mg albumin; 3ND, not detectable 
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Table 3. Prevalence of detectable samples and geometric mean level (95% confidence interval) of 
AFM1 and AF-alb in children in three villages from different regions at visit 2. 
Visit Nyabula (Iringa) Kikelelwa (Kilimanjaro) Kigwa (Tabora) 
 
AFM1 detectable (%) 
 
90 
 
59 
 
100 
 
AFM1 Geometric mean (95% 
CI)1 
 
29.3 (22.1, 38.9) 
 
12.9 (9.6, 17.5) 
 
71.0 (44.7, 112.6) 
 
AFM1 Range1 
 
AF-alb detectable (%) 
 
ND3 ± 281   
 
97 
 
ND ± 30.6  
 
36 
 
15.1 ± 1950  
 
97 
 
AF-alb geometric mean (95% 
CI)2 
 
12.4 (8.1, 18.9) 
 
3.2 (2.3, 4.3) 
 
47.3 (29.7, 75.2) 
AF-alb Range ND ± 130.5   ND ± 15  ND ± 853.3  
1AFM1, pg/ml urine; 2AF-alb, pg/mg albumin; 3ND, not detected. 
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Legends to figures 
Figure 1. The correlation between urinary AFM1 and blood AF-alb adducts (r =0.487, p <0.001). Both 
AFM1 and AF-alb adduct data are nature log transformed to obtain normal distribution. 
Figure 2. The correlation between urinary AFM1 and AFB1 contamination levels in food (r =0.468, p 
<0.001). Both AFM1 and AFB1 data are nature log transformed to obtain normal distribution. 
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Figure 1. The correlation between urinary AFM1 and blood AF-alb adducts (r =0.487, p <0.001). Both 
AFM1 and AF-alb adduct data are nature log transformed to obtain normal distribution. 
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Figure 2. The correlation between urinary AFM1 and AFB1 contamination levels in food (r =0.468, p 
<0.001). Both AFM1 and AFB1 data are nature log transformed to obtain normal distribution. 
 
 
